Cargando…
Protein aerosol for intranasal nose to brain (N2B) delivery
Autores principales: | Stützle, Martina, Carle, Stefan, Engelhardt, Lucas, Simon, Ulrich, Schafmeister, Annette, Mavoungou, Chrystelle, Schindowski, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685395/ http://dx.doi.org/10.1186/1753-6561-9-S9-O11 |
Ejemplares similares
-
Optimized fermentation conditions for improved antibody yield in hybridoma cells
por: Stützle, Martina, et al.
Publicado: (2013) -
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
por: Moreth, Jens, et al.
Publicado: (2013) -
Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review
por: Moreth, Jens, et al.
Publicado: (2013) -
Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
por: Gänger, Stella, et al.
Publicado: (2018) -
Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration
por: Soleimanizadeh, Arghavan, et al.
Publicado: (2021)